GentiBio的封面图片
GentiBio

GentiBio

生物技术

Cambridge,Massachusetts 6,517 位关注者

???? ???????? ??????????. ????????????.

关于我们

GentiBio, Inc., is an early stage biotherapeutics company co-founded by pioneers in Treg biology and synthetic immunology to develop engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory and allergic diseases. GentiBio's proprietary autologous and allogeneic EngTregs platform integrates key complimentary technologies needed to successfully restore immune tolerance and overcome major limitations in existing regulatory T-cell therapeutics. GentiBio is at the forefront of leveraging a unique therapeutic modality that can be used to address the fundamental cause of many diseases that result from overshooting and/or malfunctioning of the immune system.

网站
https://www.GentiBio.com
所属行业
生物技术
规模
51-200 人
总部
Cambridge,Massachusetts
类型
私人持股
创立
2020

地点

  • 主要

    150 Cambridgepark Dr

    US,Massachusetts,Cambridge,02140

    获取路线
  • 1930 Boren Ave 7th Fl

    US,WA,Seattle,98101

    获取路线

GentiBio员工

动态

相似主页

查看职位

融资